It is clear that metabolic diseases cannot be fully understood or treated without accounting for the role of the immune system and the signaling pathways that connect inflammatory and metabolic cues, NF-κB being emblematic for this intersection [3,5]. This evidence concerns the gene NFKB1 and metabolic disease.